BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 225 filers reported holding BRIDGEBIO PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.6%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SJS Investment Consulting Inc. | 14 | $370 | 0.00% |
| COMERICA BANK | 346 | $9,124 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 45,395 | $1,197,066 | 0.00% |
| SIGNATUREFD, LLC | 200 | $5,274 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 61,976 | $1,635 | 0.00% |
| Walleye Capital LLC | 2,500 | $65,925 | 0.00% |
| OSAIC HOLDINGS, INC. | 2,357 | $62,145 | 0.00% |
| BANK OF MONTREAL /CAN/ | 14,608 | $426,554 | 0.00% |
| Glassman Wealth Services | 15 | $396 | 0.00% |
External links
This page lists BRIDGEBIO PHARMA INC's shareholders in Q3 2023. To view BRIDGEBIO PHARMA INC's shareholder history, click here.